PARADISE-MI (Completed)
A multi-center, randomized, double-blind, active-controlled, parallel-group Phase 3 study to evaluate the efficacy and safety of LCZ696 compared to Ramipril in acute MI patients with evidence of LV dysfunction (but without prior history of chronic HF)
- Medicine
- LCZ696
- Population
- ASCVD
- Phase
- III
- Starting year
- 2016
- More information
- ClinicalTrials.gov